Form 4: ICE Director Sharon Bowen Trades Shares
Statement of Changes in Beneficial Ownership
Intercontinental Exchange Director Sharon Bowen reported a transaction involving the sale of common stock and restricted stock units under a Rule 10b5-1 trading plan.
Summary
- Director Sharon Bowen of Intercontinental Exchange, Inc. (ICE) reported a transaction on May 22, 2026.
- The transaction involved the sale of 667 shares of common stock at a price of $151.28 per share.
- This sale was executed under a pre-approved Rule 10b5-1 trading plan established on February 17, 2026.
- Following this transaction, Ms. Bowen beneficially owns 15,077 securities.
- These 15,077 securities consist of 13,539 shares of common stock and 1,538 restricted stock units (RSUs).
- The RSUs are scheduled to vest on May 18, 2027, which is the one-year anniversary of their grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While a director sale can be perceived negatively, the execution under a Rule 10b5-1 plan mitigates concerns about insider trading and suggests a pre-planned financial strategy.
Positives
- The transaction was conducted under a Rule 10b5-1 trading plan, indicating adherence to pre-determined trading strategies and potentially mitigating insider trading concerns.
- The reporting person maintains a significant beneficial ownership of 15,077 securities, including both common stock and RSUs, suggesting continued commitment to the company.
Negatives
- A director has sold a portion of their holdings, which could be interpreted negatively by the market, although it was executed under a pre-planned strategy.
Risks
- The Rule 10b5-1 trading plan, while designed to provide an affirmative defense against insider trading allegations, still relies on the plan's validity and proper execution.
- Any future sales under the plan could be perceived negatively by the market, regardless of the pre-arranged nature.
Future Outlook
The filing does not contain forward-looking statements or guidance. It is a report of a past transaction.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those under Rule 10b5-1 plans, are common for directors and executives in the financial services and exchange industry. These plans allow for scheduled stock sales or purchases, providing liquidity while aiming to avoid accusations of insider trading. The price of $151.28 per share reflects current market valuations for major exchange operators.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Trading Plan | A Rule 10b5-1 trading plan was utilized for the reported transaction, indicating adherence to established corporate governance practices for insider trading. | 02/17/2026 | Positive: Demonstrates compliance with regulatory guidelines and provides a framework for managing insider stock transactions transparently. |
Stakeholder Impact
- Shareholders: May view the sale with caution, although the Rule 10b5-1 plan provides context that it is not necessarily a negative signal about the company's future prospects.
- Management: The transaction aligns with standard practices for executive compensation and liquidity management.
- Employees: No direct impact indicated by this specific transaction.
Next Steps
- The restricted stock units are scheduled to vest on May 18, 2027.
- Future transactions by Ms. Bowen may occur under the existing Rule 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 02/17/2026 | Rule 10b5-1 trading plan approved and became effective. |
| 05/22/2026 | Transaction date for the sale of common stock. |
| 05/27/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 05/18/2027 | Vesting date for the restricted stock units. |
Keywords
Insider Trading, Rule 10b5-1, Stock Transaction, Director Sale, Intercontinental Exchange, ICE, Beneficial Ownership, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.